SEOM clinical guidelines for anaemia treatment in cancer patients (2020)


Por: Alvarez Y, Bataller R, Altozano J, Martinez S, Alvarez A, Cordellat A, Vazquez E, Jaime J, Escobar I, Zambrano C

Publicada: 1 may 2021 Ahead of Print: 1 mar 2021
Resumen:
Anaemia is defined by the presence of haemoglobin (Hb) levels < 13 g/dL in men and 12 g/dL in women. Up to 39% of cancer patients present it at the time of diagnosis and up to 40% have iron deficiency. Anaemia causes fatigue, functional deterioration and a reduction in the quality of life; it has also been associated with a poorer response to anti-tumour treatment and lower survival. Basic diagnostic tests for anaemia are simple and should be a routine part of clinical practice. These guidelines review the available evidence on the use of different therapies for treating anaemia: erythropoiesis-stimulating agents, iron supplements, and transfusion of blood products.

Filiaciones:
Alvarez Y:
 Hosp Gen Univ Gregorio Maranon, Dept Med Oncol, Madrid, Spain

Bataller R:
 Consorcio Hosp Prov Castellon, Dept Med Oncol, Castellon De La Plana, Spain

Altozano J:
 Hosp Virgen Lirios, Dept Med Oncol, Alcoy, Spain

Martinez S:
 Hosp Univ Virgen Arrixaca, Dept Med Oncol, Murcia, Spain

Alvarez A:
 Hosp Univ Puerta Mar, Dept Med Oncol, Cadiz, Cadiz, Spain

Cordellat A:
 Consorcio Hosp Gen Univ, Dept Med Oncol, Valencia, Spain

Vazquez E:
 Hospitalario Clin Univ Santiago, Dept Med Oncol, La Coruna, Spain

Jaime J:
 Clin Univ Navarra, Dept Med Oncol, Madrid, Spain

Escobar I:
 Hosp Gen Univ Virgen Nieves, Granada, Spain

Zambrano C:
 Hosp Univ Jerez Frontera, Dept Med Oncol, Cadiz, Cadiz, Spain
ISSN: 1699048X





CLINICAL & TRANSLATIONAL ONCOLOGY
Editorial
SPRINGER-VERLAG ITALIA SRL, VIA DECEMBRIO, 28, MILAN, 20137, ITALY, Italia
Tipo de documento: Article
Volumen: 23 Número: 5
Páginas: 931-939
WOS Id: 000632772700001
ID de PubMed: 33768441
imagen hybrid, Green Published

MÉTRICAS